Targaprimir-96 TFA

Targaprimir-96 TFA, a potent inhibitor of microRNA-96 (miR-96) processing, selectively reduces miR-96 production in cancer cells, thereby inducing apoptosis. This compound exhibits low nanomolar affinity binding to primary miR-96 (pri-miR-96), targeting it specifically in breast cancer cells while remaining inactive in normal breast cells [1].